Methylpropylpropanediol dinitrate

DB13408

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 222.197
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

86 Data
Dapoxetine Dapoxetine may increase the orthostatic hypotensive and hypotensive activities of Methylpropylpropanediol dinitrate.
Riociguat Methylpropylpropanediol dinitrate may increase the hypotensive activities of Riociguat.
Rosiglitazone The risk or severity of adverse effects can be increased when Methylpropylpropanediol dinitrate is combined with Rosiglitazone.
Molsidomine Molsidomine may increase the hypotensive activities of Methylpropylpropanediol dinitrate.
Tadalafil The risk or severity of hypotension can be increased when Tadalafil is combined with Methylpropylpropanediol dinitrate.
Vardenafil The risk or severity of hypotension can be increased when Vardenafil is combined with Methylpropylpropanediol dinitrate.
Dipyridamole The risk or severity of hypotension can be increased when Dipyridamole is combined with Methylpropylpropanediol dinitrate.
Ibudilast The risk or severity of hypotension can be increased when Ibudilast is combined with Methylpropylpropanediol dinitrate.
Avanafil Avanafil may increase the hypotensive activities of Methylpropylpropanediol dinitrate.
Udenafil The risk or severity of hypotension can be increased when Udenafil is combined with Methylpropylpropanediol dinitrate.
Doxofylline The risk or severity of hypotension can be increased when Doxofylline is combined with Methylpropylpropanediol dinitrate.
Mirodenafil The risk or severity of hypotension can be increased when Mirodenafil is combined with Methylpropylpropanediol dinitrate.
Fostamatinib The risk or severity of hypotension can be increased when Fostamatinib is combined with Methylpropylpropanediol dinitrate.
Ethanol Ethanol may increase the hypotensive and vasodilatory activities of Methylpropylpropanediol dinitrate.
Patent Blue The therapeutic efficacy of Methylpropylpropanediol dinitrate can be decreased when used in combination with Patent Blue.
Sildenafil The risk or severity of hypotension can be increased when Methylpropylpropanediol dinitrate is combined with Sildenafil.
Isosorbide mononitrate Methylpropylpropanediol dinitrate may increase the vasodilatory activities of Isosorbide mononitrate.
Isradipine Isradipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Diltiazem Diltiazem may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Trimethadione Trimethadione may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Amlodipine Amlodipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Nimodipine Nimodipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Nisoldipine Nisoldipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Lercanidipine Lercanidipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Cinnarizine Cinnarizine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Ethosuximide Ethosuximide may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Nicardipine Nicardipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Magnesium sulfate Magnesium sulfate may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Verapamil Verapamil may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Zonisamide Zonisamide may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Felodipine Felodipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Nitrendipine Nitrendipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Perhexiline Perhexiline may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Nifedipine Nifedipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Amiodarone Amiodarone may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Carvedilol Carvedilol may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Bepridil Bepridil may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Mibefradil Mibefradil may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Nimesulide Nimesulide may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Prenylamine Prenylamine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Cyclandelate Cyclandelate may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Flunarizine Flunarizine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Fluspirilene Fluspirilene may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Clevidipine Clevidipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Methsuximide Methsuximide may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Seletracetam Seletracetam may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Nylidrin Nylidrin may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Dotarizine Dotarizine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Nilvadipine Nilvadipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Tranilast Tranilast may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Fasudil Fasudil may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Agmatine Agmatine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Fendiline Fendiline may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Eperisone Eperisone may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Trimebutine Trimebutine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Pinaverium Pinaverium may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Barnidipine Barnidipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Aranidipine Aranidipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Azelnidipine Azelnidipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Benidipine Benidipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Cilnidipine Cilnidipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Darodipine Darodipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Efonidipine Efonidipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Lacidipine Lacidipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Manidipine Manidipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Niguldipine Niguldipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Niludipine Niludipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Carboxyamidotriazole Carboxyamidotriazole may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Naftopidil Naftopidil may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Tetrahydropalmatine Tetrahydropalmatine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Vinpocetine Vinpocetine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Gallopamil Gallopamil may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Bencyclane Bencyclane may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Otilonium Otilonium may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Terodiline Terodiline may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Lidoflazine Lidoflazine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Penfluridol Penfluridol may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Caroverine Caroverine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
WIN 55212-2 WIN 55212-2 may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Dexverapamil Dexverapamil may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Emopamil Emopamil may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Lomerizine Lomerizine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Tetrandrine Tetrandrine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Dexniguldipine Dexniguldipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Levamlodipine Levamlodipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
Iloprost Iloprost may increase the hypotensive activities of Methylpropylpropanediol dinitrate.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul